Icon boosts bioanalytical presence through Prevalere buy
4 Minuten
Podcast
Podcaster
Beschreibung
vor 17 Jahren
Icon's recent $43.2m acquisition of New York-based Prevalere Life
Sciences is the latest part of the firm's expansion in the US CRO
market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical
development, Brian O'Dwyer, and Prevalere CEO Mario Rocci from a
busy AAPS conference in Atlanta.
Sciences is the latest part of the firm's expansion in the US CRO
market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical
development, Brian O'Dwyer, and Prevalere CEO Mario Rocci from a
busy AAPS conference in Atlanta.
Weitere Episoden
3 Minuten
vor 11 Jahren
3 Minuten
vor 12 Jahren
5 Minuten
vor 12 Jahren
4 Minuten
vor 12 Jahren
7 Minuten
vor 12 Jahren
In Podcasts werben
Kommentare (0)